Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
10% from low
Exchange
OTC Link
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $5.5K | $195.7K | $104.6K | $204.3K | $294.7K | $391.7K |
| Cost of revenue | $0 | $0 | $3.4K | $144.3K | $1.6M | $35.7K | $124.9K | $52.6K |
| Gross profit | $0 | $0 | $2.1K | $51.4K | −$1.5M | $168.6K | $169.8K | $339.1K |
| Gross margin | — | — | 38.5% | 26.2% | -1417.9% | 82.5% | 57.6% | 86.6% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$58.1K | −$46.8K | −$46.2K | −$243.6K | −$4.7M | −$492.6K | −$782.7K | −$382.9K |
| EBITDA | $0 | $0 | $0 | −$249.0K | −$4.7M | −$447.3K | −$767.9K | −$382.9K |
| Net income | −$59.4K | −$65.0K | −$51.9K | −$269.1K | −$4.9M | −$761.4K | −$1.2M | −$721.2K |
| Net margin | — | — | -948.4% | -137.5% | -4650.0% | -372.7% | -414.2% | -184.1% |
| EPS (diluted) | -0.00 | -0.00 | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
AMERICA GREAT HEALTH
No one on the platform currently holds AAGH.
No tracked institution reports a position in AAGH as of their last filing.
| Execution date | Ratio |
|---|---|
| 2012-10-10 | 10-for-1 |
No one on the platform has traded AAGH yet.
| $1M |
| — |
| HESGHealth Sciences Group, Inc. | $0.00 | +0.00% | $2M | — |
| IBOGFUniversal Ibogaine Inc. | $0.03 | +3.81% | $8M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 5.0× sales vs its 694.5× historical median P/S.
Fair value ≈ $0.01 · price $0.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.